Devora Schiff
Impact in
-
- MicroRNA in disease regulation
-
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
- Oncology 10
- Cancer-related Molecular Pathways 5
- PARP inhibition in cancer therapy 4
- CAR-T cell therapy research 2
-
- DNA Repair Mechanisms 3
- Cancer therapeutics and mechanisms 2
- Co-authors
- Bruce G. Haffty (16 shared papers)Sharad Goyal (11 shared papers)Atif J. Khan (4 shared papers)Monal Mehta (2 shared papers)Meena S. Moran (6 shared papers)Sachin R. Jhawar (5 shared papers)Hao Wu (1 shared paper)Caitlin A. Schonewolf (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (7 papers)Oncotarget (2 papers)Clinical Cancer Research (1 paper)Journal of Clinical Oncology (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesChinaNetherlands
In The Last Decade
Devora Schiff
18 papers receiving 324 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 72
- Oncology 109
- Pharmaceutical Science 24
- Molecular Biology 209
- Geriatrics and Gerontology 9
Countries citing papers authored by Devora Schiff
This map shows the geographic impact of Devora Schiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devora Schiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devora Schiff more than expected).
Fields of papers citing papers by Devora Schiff
This network shows the impact of papers produced by Devora Schiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devora Schiff. The network helps show where Devora Schiff may publish in the future.
Co-authors
The 25 scholars most cited alongside Devora Schiff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 60 | |
| 2 | 2018 | 44 | |
| 3 | 2011 | 34 | |
| 4 | 2012 | 30 | |
| 5 | 2014 | 30 | |
| 6 | 2019 | 22 | |
| 7 | 2013 | 22 | |
| 8 | 2010 | 21 | |
| 9 | 2013 | 21 | |
| 10 | 2009 | 13 | |
| 11 | 2010 | 11 | |
| 12 | 2013 | 10 | |
| 13 | 2017 | 3 | |
| 14 | 1998 | 1 | |
| 15 | 2009 | 1 | |
| 16 | 2017 | 1 | |
| 17 | 2009 | 1 | |
| 18 | 2018 | 1 |
About Devora Schiff
Devora Schiff is a scholar working on Oncology, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 326 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), PARP inhibition in cancer therapy (4 papers), DNA Repair Mechanisms (3 papers), Breast Cancer Treatment Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Cancer therapeutics and mechanisms (2 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (72 citations), Oncology (109 citations), Pharmaceutical Science (24 citations), Molecular Biology (209 citations) and Geriatrics and Gerontology (9 citations). Devora Schiff has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Bruce G. Haffty, Sharad Goyal, Atif J. Khan, Monal Mehta, Meena S. Moran, Sachin R. Jhawar, Hao Wu, Caitlin A. Schonewolf, Salma K. Jabbour and Hao Wu. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Oncotarget, Clinical Cancer Research, Journal of Clinical Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.